Antiplatelet Therapy for Ischemic Heart Disease [5] (multiple letters)

New England Journal of Medicine

Volumn 350, Issue 20, 2004, Pages 2101-2102

  Steimle, Anthony E ^a   Lange, Richard A ^b   Hillis, L David ^b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

BLEEDING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEATH; DRUG COST; DRUG EFFICACY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; HEART MUSCLE ISCHEMIA; NOTE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 2342503906     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200405133502020     Document Type: Letter

References (0)